trending Market Intelligence /marketintelligence/en/news-insights/trending/3fy87xmpcsgcv5kzmetl3w2 content esgSubNav
In This List

Profound Medical upsizes bought-deal offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Profound Medical upsizes bought-deal offering

Profound Medical Corp. upsized a previously announced bought-deal offering and now plans to raise gross proceeds of C$30 million.

The Ontario-based company said it will now offer 30 million units at C$1 apiece. Each unit will comprise 1 common share and 0.5 of a five-year warrant to buy an additional share for C$1.40.

Additionally, the medical device company agreed to grant the underwriters a 30-day overallotment option to buy up to an additional 4.5 million units at the offering price.

The syndicate of underwriters is led by Canaccord Genuity Corp.

The offering is expected to close on or about March 20, subject to certain closing conditions.